<DOC>
	<DOCNO>NCT01941147</DOCNO>
	<brief_summary>There great interest development novel therapy acute ischemic stroke , date , thrombolysis approve treatment . Recent evidence suggest extremely low frequency magnetic field ( ELF-MF ) could alternative approach acute ischemic stroke therapy effect main mechanism brain ischemic damage regeneration.The main purpose open label , one arm , dose escalation study validation ELF-MF stimulation non-invasive , safe effective tool promote recovery acute ischemic stroke patient Nine patient treat daily 5 consecutive day , start within 48 h onset stroke . Three dose cohort three patient , stimulate pulse ELF-MF ( 75 Hz , 1,8 mT ) increase daily exposure ( 45 , 120 , 240 min ) .The primary outcome ( safety endpoint ) evaluate incidence adverse event mortality throughout stimulation period 1-year follow-up . Secondary outcome consist change baseline clinical radiological score .</brief_summary>
	<brief_title>Extremely Low Frequency Magnetic Fields Acute Ischemic Stroke</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<criteria>male female , age 18 evidence monohemispheric ischemic stroke confirm brain MRI first onset stroke patient onset symptom within 48 hour prior enrollment National Institutes Health Stroke Scale ( NIHSS ) score great 4 patient alert , medically stable accord treat physician able follow simple verbal command sign write informed consent prior entry study acute intracranial hemorrhage confirm brain CT MRI scan previous ischemic hemorrhagic stroke seizure onset stroke history epilepsy contraindication transcranial magnetic stimulation : implant metallic part implant electronic device , include pacemaker , defibrillator , implanted medication pump , implant brain stimulator aneurysm clip metal body life expectancy le 3 month serious illness , e.g. , severe hepatic , cardiac , renal failure , acute myocardial infarction , complex disease may confound treatment assessment woman know pregnant , lactate positive indeterminate pregnancy test condition would prevent subject give voluntary informed consent current participation another study investigational drug device</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Acute Stroke</keyword>
	<keyword>Brain Ischemia</keyword>
	<keyword>Extremely Low Frequency Magnetic Fields</keyword>
</DOC>